TSHA - CIK 0001806310
Taysha Gene Therapies, Inc. has filed 386 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (101 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SEC correspondence | UPLOAD | 2024-12-18 | - |
| Securities registration | S-3 | 2024-12-13 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake | SC 13G | 2024-11-14 | - |
| Major company event | 8-K | 2024-11-13 | 2024-11-13 |
| Quarterly report | 10-Q | 2024-11-13 | 2024-09-30 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-12 | - |
| Passive ownership stake | SC 13G | 2024-11-08 | - |
| Passive ownership stake | SC 13G | 2024-10-22 | - |
| Major company event | 8-K | 2024-08-12 | 2024-08-12 |
| Quarterly report | 10-Q | 2024-08-12 | 2024-06-30 |
| Insider sale notice | 144 | 2024-07-05 | - |
| Insider sale notice | 144 | 2024-07-05 | - |
| Insider sale notice | 144 | 2024-07-05 | - |
| Insider trade | 4 | 2024-07-01 | 2024-06-27 |
| Major company event | 8-K | 2024-06-26 | 2024-06-26 |
| Prospectus supplement | 424B5 | 2024-06-26 | - |
| Major company event | 8-K | 2024-06-26 | 2024-06-25 |
| Prospectus supplement | 424B5 | 2024-06-26 | - |
| Major company event | 8-K | 2024-06-18 | 2024-06-18 |
| Insider trade | 4 | 2024-05-31 | 2024-05-29 |
| Insider trade | 4 | 2024-05-31 | 2024-05-29 |
| Insider trade | 4 | 2024-05-31 | 2024-05-29 |
| Insider trade | 4 | 2024-05-31 | 2024-05-29 |
| Major company event | 8-K | 2024-05-30 | 2024-05-29 |
| Major company event | 8-K | 2024-05-14 | 2024-05-14 |
| Quarterly report | 10-Q | 2024-05-14 | 2024-03-31 |
| Proxy materials | DEFA14A | 2024-04-18 | - |
| Annual report to shareholders | ARS | 2024-04-18 | 2023-12-31 |
| Proxy statement | DEF 14A | 2024-04-18 | 2024-05-29 |
| Employee stock plan | S-8 | 2024-03-19 | - |
| Major company event | 8-K | 2024-03-19 | 2024-03-19 |
| Annual report | 10-K | 2024-03-19 | 2023-12-31 |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake | SC 13G | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-09 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-09 | - |
| Insider trade | 4 | 2024-02-06 | 2024-02-02 |
| Major company event | 8-K | 2024-01-10 | 2024-01-10 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Major company event | 8-K | 2023-12-20 | 2023-12-14 |
| Employee stock plan | S-8 | 2023-12-20 | - |
| Insider trade | 4 | 2023-12-18 | 2023-12-14 |
| Insider trade | 4 | 2023-12-18 | 2023-12-14 |
| Insider trade | 4 | 2023-12-18 | 2023-12-14 |
| Insider trade | 4 | 2023-11-20 | 2023-11-17 |